PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 11, 2026Molecular Psychiatry0 citations

Cerebellar microglia-derived IL-17A mitigates autism-related behavioral and synaptic deficits

View Full Paper
JYJun YinWLwei LiLSLi-Ping Shen

Key Points

  • This research seeks to understand the role of IL-17A derived from microglia in autism-related behavioral deficits.
  • Utilized Fmr1-KO mice as a genetic model for autism spectrum disorder.
  • Administered IL-17A to assess effects on social behaviors and synaptic function.
  • Induced IL-17A release using poly(I:C) to evaluate changes in Purkinje cells' excitability.
  • IL-17A signaling was aberrant in the cerebellum of Fmr1-KO mice.
  • Administration of IL-17A improved neuronal excitability and reduced symptoms associated with autism.
  • Downregulation of IL-17 receptor signaling resulted in ASD-like social deficits.

Abstract

Interleukin-17 (IL-17) is a pleiotropic cytokine produced mainly by peripheral T helper 17 cells. Yet, the brain functions of IL-17 derived from central nervous cells remain poorly understood. Here, we find an aberrant IL-17A signaling in the cerebellum of Fmr1- KO mice, a well-established genetic model for autism spectrum disorder (ASD). Cerebellar IL-17A, derived exclusively from microglia, is essential for the regulation of social behaviors by maintaining neuronal excitability and selectively suppressing inhibitory neurotransmission of Purkinje cells (PCs) in the cerebellar Crus I, a brain region critically involved in social cognition. Specific downregulation of IL-17 receptor-mediated signaling in cerebellar PCs recapitulates ASD-like social deficits and repetitive behaviors. Notably, both direct administration of IL-17A and induction of IL-17A release from cerebellar microglia by poly(I:C) effectively restore PC excitability and ameliorate ASD-like symptoms. The findings uncover an indispensable role of microglia-derived IL-17A for cerebellar social processing and suggest potential therapeutic strategies targeting IL-17A signaling for ASD.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yin et al. (2026) studied this question.

synapsesocial.com/papers/698be001058ab1890a13ba41https://doi.org/10.1038/s41380-026-03454-1
Ask AI
Helpful
Bookmark
Share
View Full Paper